Latest Breaking News On - Nrg gy019 trial - Page 1 : comparemela.com

Although there are no FDA-approved treatments specifically indicated for low-grade serous ovarian cancer, therapeutic options for these patients are rapidly expanding, with promising new approaches progressing through clinical development.

United statesWashington universityDavidm omalleyPremalh thakerShannonn westinOnclive news networkDepartment of obstetricsDivision of gynecologic oncologyOhio state university college of medicineUniversity of texas md anderson cancer centerOhio state university comprehensive cancer centerDepartment of gynecologic oncologyDivision of surgeryEmerging therapiesLow grade serous ovarian cancerGynecologic oncology